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SUMMARY 
The prevalence of Trichomonas vaginalis infection at two federal, female-only prisons was 
8.5%. Positive women were more likely to report a lower income before arrest than negative 
women. 
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ABSTRACT 
Background: Previous studies have observed high prevalences of Trichomonas vaginalis 
infection among women entering U.S. jails and state prisons (22-47%). We sought to determine 
the prevalence among women incarcerated in two U.S. female-only federal prisons. 
Methods: Female inmates were recruited at two prisons (n=624). Participants completed a self-
administered questionnaire and provided self-collected first-catch urine and vaginal swab 
specimens. Specimens were tested for T. vaginalis DNA.   
Results: 8.5% of participants at the first prison, and 8.3% at the second prison had a positive 
urine result, vaginal swab result or both, for a combined prevalence of 8.5%. Using positivity in 
either specimen as the reference standard, urine PCR had a sensitivity of 66.7% and vaginal 
swab PCR had a sensitivity of 84.4%. The only significant positive correlate of T. vaginalis 
infection was lower household income before arrest. Other variables non-significantly positively 
correlated with T. vaginalis were being employed at the time of arrest, having experienced 
sexual, physical or emotional abuse by a family member, having a parent who had not had a drug 
or alcohol addiction, never exchanging sex for money or drugs, ever being pregnant, having 
abnormal vaginal bleeding/spotting, and having concurrent chlamydia or gonorrhea.  
Conclusions: Although not as high as in other studies of women entering U.S. jails and state 
prisons, our observed T. vaginalis prevalence of 8.5% was much higher than in the general U.S. 
population. Therefore, screening for T. vaginalis infection may be warranted at federal prison 
entry, as well as sexual health education during prison stay. 
Key words: Trichomonas vaginalis, female, prison, prevalence, epidemiology
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INTRODUCTION 
Previous studies have observed high prevalences of sexually transmitted infections (STIs) 
among women entering jail and juvenile corrections facilities.1 In a study of adult women 
entering correctional facilities in several U.S. states and Puerto Rico, the median prevalence of 
chlamydia was 6.4%, and those of gonorrhea and syphilis were 2.9% and 2.1%, respectively.1 
Less is known about the prevalence of Trichomonas vaginalis infection among incarcerated 
women. T. vaginalis is a common, sexually transmitted protozoan known to cause vaginitis and 
adverse birth outcomes, such as premature rupture of the membranes, in women, and increased 
risk and transmission of human immunodeficiency virus infection.2 In the two surveys of T. 
vaginalis conducted to date among incarcerated women, high prevalences of infection have been 
observed, ranging from 22% among non-pregnant inmates3 to 47% among newly-incarcerated 
pregnant inmates.4 
We previously investigated prevalences of chlamydia and gonorrhea in female U.S. 
federal prison inmates, and found the prevalence of chlamydia to be high among women <30 
years of age (prison 2: 3.5%), but low among all participants combined (prison 1: 
chlamydia=1.2%, gonorrhea=0.3%; prison 2: chlamydia=2.3%, gonorrhea=0.0%).5 This finding 
was not entirely unexpected because women at the first prison were screened for chlamydia and 
gonorrhea at entry, and women at the second prison may have been screened and treated before 
being transferred to federal prison, or treated earlier in their prison stay. Additionally, federal 
prison inmates tend to be older than those in jails and corrections facilities, and are thus at 
possibly lesser risk for chlamydia and gonorrhea and greater risk for T. vaginalis infection, as the 
risk of chlamydia and gonorrhea typically decreases with age, and that of T. vaginalis infection 
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typically increases with age beyond adolescence.6 Therefore, we investigated the prevalence and 
correlates of T. vaginalis infection in this older female incarcerated population.  
MATERIALS AND METHODS 
Study population 
Study participants were recruited from two U.S. female-only federal prisons. The first 
prison, located in the Midwest, screened all inmates for chlamydia and gonorrhea at entry 
(screening prison, SP), while the second prison, located in New England, only tested inmates for 
STIs if they presented with signs or symptoms of infection (non-screening prison, NSP). Female 
inmates learned about the study at gatherings for group announcements (“call-outs”) held from 
August-October, 2001 at each prison. Only women 18-45 years of age were invited to attend 
call-out. Women who consented to participate in the study completed a self-administered 
questionnaire and provided self-collected urine and vaginal swab specimens. No incentives were 
provided for participation. Further details of study procedures were described elsewhere.5   
This study was approved by the institutional review boards of the Uniformed Services 
University of the Health Sciences, the Federal Bureau of Prisons, and the Johns Hopkins Medical 
Institutions.  
Data collection 
On the questionnaire, women were asked to provide information on demographics; 
reason and length of incarceration; substance use, sexual and reproductive history; and current 
STI symptoms. This questionnaire was developed based on focus groups and group-based 
cognitive interviews with female federal prison inmates,7 and was available in English and 
Spanish. Following completion of the questionnaire, women were asked to provide 
approximately 20 mL of first-catch urine and a vaginal swab. Specimens were stored at 4°C and 
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transported to the laboratory for processing within four days of collection. They were then 
maintained frozen at -80°C until testing.  
Laboratory methods 
Urine and vaginal swabs were tested for T. vaginalis DNA by BTUB FRET real-time 
PCR. In a previous validation study, this assay had a sensitivity of 90.5% in male and female 
thawed urine specimens, and a specificity of 100%.8  
Statistical analysis 
Proportions of women positive for T. vaginalis by urine PCR, swab PCR and 
combinations of these two methods were calculated separately for each prison, and for both 
prisons combined. T. vaginalis correlates were investigated by calculating medians or 
proportions of each covariate by T. vaginalis status, and comparing these estimates by Wilcoxon 
rank sum tests or Chi-squared/Fisher’s exact tests, as appropriate. T. vaginalis positivity was 
defined as a positive urine result, swab result, or both. Sensitivity analyses were performed using 
two alternate case definitions: 1) a positive urine result, and 2) a positive swab result. Stratified 
analyses were performed by race (African-American, non-African-American) and duration of 
incarceration (<2, ≥2 years). 
RESULTS 
Of the approximately 1,344 female inmates eligible for the study, 1,230 (91.5%, 90% at 
the SP and 93% at the NSP) attended call-out. Reasons for not attending call-out included 
confinement in a secure housing unit, illness, inability to be released from work, or personal 
choice. 988 inmates (80.3%) who attended call-out volunteered to participate in the study and 
completed the self-administered questionnaire, 363 from the SP and 625 from the NSP. Of those 
who volunteered at the SP, 331 provided urine and swab specimens, 27 provided only urine, and 
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5 provided only swabs. Due to time constraints at the SP, 117 additional women were unable to 
complete the questionnaire, but did provide either urine (n=17), swabs (n=2) or both (n=98) for 
testing. Thus, 473 urine and 436 swab specimens were available for testing at the SP. At the 
NSP, 614 participants originally provided either urine or swabs. However, several boxes of these 
specimens (77% of specimens) were discarded after chlamydia and gonorrhea testing to create 
additional freezer space before the decision was made to perform T. vaginalis testing. Boxes 
were originally filled in order of participation, and were discarded at random; therefore, it is 
unlikely that discarded specimens differed from non-discarded specimens by T. vaginalis or 
correlate status. After discarding specimens, 142 urine and 79 swab specimens remained from 
the NSP, 77 urine and swab specimens from the same participant, 65 individual urine specimens 
and 2 individual swabs.  
At the SP, 27 (5.7%) participants had a positive urine result and 35 (8.0%) had a positive 
vaginal swab result, for a total of 41 (8.5%, 95% confidence interval (CI): 6.0-11.0%) 
participants positive by either test. At the NSP, 11 (7.7%) participants had a positive urine result 
and 3 (3.8%) had a positive swab result, for a total of 12 (8.3%, 95% CI: 3.8-12.8%) positive 
using either specimen. When information from both prisons was combined, 53 (8.5%, 95% CI: 
6.3-10.7%) participants had a positive urine result, swab result or both. Considering only women 
who provided both specimens (n=506), 7 (1.4%) were positive by urine results only, 15 (3.0%) 
by swab results only, and 23 (4.6%) by both specimens (Table 1). Among these women, the 
sensitivity of urine PCR was 66.7% (95% CI: 52.9-80.4%) and that of swab PCR was 84.4% 
(95% CI: 73.9-95.0%) using positivity in either specimen as the reference standard.   
As the total number of positive participants was low and as similar prevalences were 
observed at each prison, T. vaginalis correlates were investigated using the combined data for 
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both prisons. In this analysis, T. vaginalis positivity was defined as a positive urine result, swab 
result, or both. No differences were observed between T. vaginalis-positive and -negative women 
by age, race/ethnicity, education or marital status. Positive women were non-significantly more 
likely to have been born outside the continental U.S. than negative women, although this finding 
was driven by urine results. No correlation was observed when infection was defined by a 
positive swab result (Table 2 and data not shown).  
T. vaginalis-positive women were significantly more likely to have had a legal or illegal 
household income ≤$15,000, and non-significantly more likely to have been legally employed 
before their arrest than -negative women, irrespective of the case definition. No differences were 
observed by type of crime committed (only one participant reported incarceration for 
prostitution), or length of incarceration. Additionally, no differences were observed by cigarette 
smoking or use of illegal drugs or controlled substances in the 12 months before arrest. Among 
women who reported using illegal drugs or controlled substances during this time, positive 
women tended to be more likely to have used marijuana, and less likely to have used 
methamphetamines or other drugs, such as LSD, PCP or barbiturates. Positive women were non-
significantly more likely to report sexual, physical or emotional abuse by a family member, and 
less likely to report parental drug or alcohol addiction. No differences were observed by parental 
incarceration (Table 2).  
With respect to sexual history, no differences were observed between T. vaginalis-
positive and -negative women by lifetime history of vaginal intercourse with a male partner, or 
recent history before prison entry. No differences were also observed by lifetime history of any 
form of sexual intercourse with a female partner. Null results were observed both before and 
after taking into consideration consistency of participant responses across related sexual history 
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questions. Positive women were non-significantly less likely to have ever exchanged sexual 
activity for money or drugs, and non-significantly more likely to have ever been pregnant. No 
differences were observed by method of birth control or reported pelvic examination in the 
twelve months before arrest (Table 3). 
With respect to current symptoms, T. vaginalis-positive women were non-significantly 
more likely to report an abnormal/unusual discharge and vaginal bleeding/spotting other than 
their normal period than -negative women. The correlation between abnormal/unusual discharge 
and infection was more pronounced for positive urine results. When only swab results were 
considered, positive women were more likely to report lower abdominal/pelvic pain. Finally, 
positive women were non-significantly more likely to have concurrent chlamydia or gonorrhea, a 
finding that was more pronounced for positive swab results. Generally similar correlates were 
observed when the analyses were stratified by race and two years’ incarceration. Too few 
positive women were incarcerated for <1 year to stratify by one year’s incarceration (Table 3 and 
data not shown).  
DISCUSSION 
The prevalence of T. vaginalis infection among female prison inmates at two U.S. federal 
prisons was 8.5%. More infections were detected by self-collected vaginal swab than urine. The 
only significant positive correlate of T. vaginalis was lower income. Other variables that 
appeared to be positively correlated with infection, but that were not statistically significant, 
included being employed at the time of arrest, having experienced sexual, physical or emotional 
abuse by a family member, having a parent who had not had a drug or alcohol addiction, never 
exchanging sexual activity for money or drugs, ever being pregnant, having abnormal vaginal 
bleeding/spotting, and having concurrent chlamydia or gonorrhea. A positive urine result was 
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additionally correlated with being born outside the continental U.S. and having an 
abnormal/unusual discharge, while a positive swab result was additionally correlated with a 
greater likelihood of lower abdominal/pelvic pain. Interestingly, length of incarceration and 
sexual history were not correlated with infection by any definition.  
Relative to other incarcerated populations, in which prevalences as high as 22-47% have 
been observed,3, 4 our observed prevalence of 8.5% is low. This finding is not surprising because 
a lower proportion of women in our federal prison population reported exchanging sexual 
activity for money/drugs than in other incarcerated populations (17% versus 27-29%3, 4), and 
because women in our population had been incarcerated for a longer period of time (median=19 
months versus at entry3, 4), allowing for greater opportunity for screening, treatment for 
symptoms, or spontaneous cure. However, when compared to general population estimates (2.8-
3.1%9, 10), our observed prevalence of 8.5% is high. One possible explanation for this difference 
may be the greater likelihood of high-STI risk correlates/behaviors, such as African-American 
race,11 lower education,10, 12-14 lower income,10, 13, 14 greater sexual experience/history,10, 12-15 
illegal drug use,4, 14-19 and previous or concomitant STIs,4, 9, 12-14, 17, 20 in our prison population 
than in the general population. Within our study population, however, these high-STI risk 
correlates/behaviors were not correlated with T. vaginalis, with the exception of lower income 
and possibly concomitant STIs. The reasons for these differing correlations are unclear, but 
perhaps once incarceration is held constant, factors such as race/ethnicity, lower education, 
sexual experience/history and illegal drug use are no longer as correlated with infection as in less 
highly-selected populations, although correlations have been observed in other highly-selected 
populations.4, 12-18, 20, 21 The interpretation of the positive correlation with lower income in our 
study population is also difficult because no correlation was observed with education, which is 
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typically correlated with income, and a non-significant positive correlation was observed with 
full- or part-time employment, which is typically correlated with higher income. However, 
perhaps in our study population, full- or part-time employment was correlated with lower total 
family income because it represented the need for employment by female single heads of 
households, or a lesser likelihood of illegal contributions to household income.   
As stated earlier, no correlation was observed for length of incarceration, which ranged 
from 1 month to almost 11 years among positive women (median=18.5 months). This lack of 
correlation raises the question as to whether detected infections were long-term infections 
acquired before incarceration, short-term infections acquired in prison, or possibly misreported 
lengths of incarceration. T. vaginalis has been observed to persist for at least 12 weeks to 1 year 
in women;16, 22, 23 therefore, it is possible that some infections may have been acquired before 
incarceration and persisted until the study date. Alternatively, although no evidence of within-jail 
infection was observed at a county correctional center,24 some infections may potentially have 
been acquired in our prison population through sexual relationships with prison staff members or 
fellow inmates, as infection has been observed following lesbian sexual activities.25, 26 Therefore, 
detected T. vaginalis infections may represent a combination of infections acquired before prison 
and during prison stay, making it difficult to identify correlates of prevalent infection. We 
attempted to investigate possible differing correlates for infections acquired before or during 
prison stay by stratifying the analyses by length of incarceration, as participants incarcerated for 
a lesser amount of time may have been more likely to have been infected before prison entry, and 
participants incarcerated for a greater amount of time may have been more likely to have been 
infected in prison. However, no additional correlates were identified when we stratified the 
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analyses by two years’ incarceration, and too few positive women were incarcerated for <1 year 
to stratify by one year’s incarceration.   
Another factor that may have contributed to difficulties in identifying T. vaginalis 
correlates is some inconsistencies in participants’ self-reported responses, particularly those 
related to sexual history. One possible reason for these inconsistencies, which emerged in focus 
group discussions, is a general mistrust of how study information might be used, particularly 
information on sensitive or illegal topics, such as sexual activity in prison.7 To reduce this 
concern, we limited sexual activity questions to the period of time before prison entry, or 
inquired about participants’ entire sexual history. Nevertheless, some questions that incorporated 
information on sexual activity during prison stay may not have been answered truthfully. 
Another possible reason for inconsistencies is the distinction between consensual sexual 
relationships, and sexual abuse or rape, which was reported by a large proportion of inmates in 
group discussions. Whether participants included sexual abuse/rape in their responses to 
questions on sexual history is unclear. We attempted to address inconsistencies in participants’ 
responses to sexual history questions by investigating both participants’ original responses and 
those found to be consistent across related questions, neither of which was correlated with T. 
vaginalis in overall, race-specific or duration of incarceration-specific analyses. 
With respect to assessment of the outcome, the PCR assay used had a high sensitivity and 
specificity for T. vaginalis,8 and use of two different specimens should have increased the 
sensitivity further. However, some infections may still have been missed due to use of thawed 
rather than fresh specimens, as T. vaginalis DNA is less stable in thawed specimens. Therefore, 
the actual prevalence of T. vaginalis in our prison population may have been even higher than 
observed. When we considered the sensitivity of each of the two specimens/methods separately, 
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we found that vaginal swab PCR had a higher sensitivity than urine PCR. This finding is 
consistent with the results from several previous studies,27-30 and the more frequent localization 
of T. vaginalis to the vagina than the urethra.2 It may also possibly be explained by lower 
stability of T. vaginalis DNA in urine than swabs both before and during storage.31 Despite these 
differences, most identified correlates were similar for urine and swab PCR. One exception was 
symptoms; women positive by urine PCR were non-significantly more likely to report an 
abnormal/unusual vaginal discharge, whereas women positive by swab PCR were non-
significantly more likely to report lower abdominal/pelvic pain than negative women. The 
reasons for these differences are unclear. Perhaps, in the case of the stronger positive correlation 
between abnormal/unusual vaginal discharge and urine positivity, urine PCR is better at 
detecting infections associated with discharge because of contamination of the urethral area by 
vaginal discharge, whereas vaginal swab PCR may be equally good at detecting infections with 
or without discharge. For the positive correlation between abdominal/pelvic pain and vaginal 
swab positivity, possibly higher vaginal parasite load in women with T. vaginalis-associated 
abdominal/pelvic pain may make it easier to detect infections by swab than urine.  
As a final consideration and possible limitation, our ability to detect statistically 
significant correlations may have been low due to the relatively small number of positive women 
in our study population. Additionally, some observed correlations, particularly those that were 
not statistically significant and those that were not observed for both urine and swab PCR, may 
have been observed by chance. 
In conclusion, although our observed T. vaginalis prevalence of 8.5% was not as high as 
in other studies of women entering U.S. jails and state prisons, it was still considerably higher 
than in the general U.S. population. It was also higher than prevalences of chlamydia and 
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gonorrhea in the same study population, even among the subgroup of women with the highest 
prevalence, i.e., those <30 years of age (3.5% for chlamydia) for whom the Federal Bureau of 
Prisons modified their screening protocol to a more targeted age-based approach.5 Therefore, 
given the higher observed prevalence of T. vaginalis infection in this population, we believe that 
universal T. vaginalis screening at federal prison entry may also be warranted, as well as sexual 
health education during prison stay.  
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Table 1:  Detection of Trichomonas vaginalis by PCR in urine and vaginal swabs from 624 female inmates at two U.S. federal prisons, 2001 
Screening prison1 Non-screening prison2  Both prisons 
Urine  Swab N n (%) Urine  Swab N n (%) Urine  Swab N n (%) 
Positive  * 473 27 (5.7) Positive  * 142 11 (7.7) Positive  * 615 38 (6.2) 
*  Positive 436 35 (8.0) *  Positive 79 3 (3.8) *  Positive 515 38 (7.4) 
Positive  or Positive 480 41 (8.5) Positive  or Positive 144 12 (8.3) Positive  or Positive 624 53 (8.5) 
Negative  Negative 429 391 (91.1) Negative  Negative 77 70 (90.9) Negative  Negative 506 461 (91.1) 
Positive  Negative 429 3 (0.7) Positive  Negative 77 4 (5.2) Positive  Negative 506 7 (1.4) 
Negative  Positive 429 14 (3.3) Negative  Positive 77 1 (1.3) Negative 
 
Positive 506 15 (3.0) 
Positive  Positive 429 21 (4.9) Positive  Positive 77 2 (2.6) Positive  Positive 506 23 (4.6) 
*  Positive, negative or not tested. 
1
 All women were screened for chlamydia and gonorrhea upon entry at the screening prison. 
2
 Women were tested for sexually transmitted infections if they presented with signs or symptoms of infection at the non-screening prison. 
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Table 2:  Demographic, incarceration, substance use and familial characteristics of female inmates at two 











Age (years, %):     
<25 15.0 10.4 15.4  
25-34 41.7 47.9 41.1 0.53 
≥35 43.3 41.7 43.5  
Race/ethnicity (%):     
African-American 41.4 41.7 41.3  
Caucasian 38.8 33.3 39.3  
Hispanic 10.0 12.5 9.8 0.79 
Other race/ethnicity 6.6 8.3 6.4  
Mixed race/ethnicity 3.2 4.2 3.1  
Education (%):     
Elementary school or less 7.3 6.2 7.4  
Some high school or high school degree 56.0 52.1 56.5 0.74 
Some college or higher 36.6 41.7 36.1  
Marital status (%):     
Never married 42.6 42.6 42.6  
Married  34.6 27.7 35.4 0.40 
Divorced, separated or widowed 22.8 29.8 22.0  
Birth outside the continental U.S. (%) 14.4 23.4 13.5 0.07 
Household income (%):     
≤$15,000 30.4 47.9 28.5  
>$15,000 52.3 37.5 53.8 0.02 
Don’t know or missing information 17.4 14.6 17.6  
Full- or part-time employment (%) 66.1 78.3 64.8 0.07 
Type of crime committed (%):     
White collar 13.9 13.3 13.9  
Drug or violence-related  82.9 84.4 82.8 0.92 
Other 3.2 2.2 3.3  







Any cigarette smoking in the 12 months before arrest (%) 65.0 66.0 64.9 0.88 
Any drug use in the 12 months before arrest (%)  70.3 63.8 71.0 0.30 
Drugs used in the past 12 months before arrest (%)3:      
Marijuana 74.4 86.7 73.2 0.11 
Crack/cocaine 52.1 50.0 52.3 0.81 
Heroin 12.2 6.7 12.8 0.56 
Methamphetamines 19.9 10.0 20.9 0.15 
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Other drugs 25.1 13.3 26.2 0.12 
Ever been a victim of sexual, physical or emotional abuse 
by a family member (%) 
36.1 45.8 35.1 0.14 
Either parent ever had a drug or alcohol addiction (%) 44.2 33.3 45.4 0.11 
Either parent ever been incarcerated (%) 20.7 21.3 20.6 0.92 
1 Total number may vary slightly for each characteristic due to missing responses. 
2 P-values were calculated by Wilcoxon rank sum tests for continuous variables, and Chi-squared or Fisher’s exact 
tests for binary and categorical variables.  
3
 Among women who used drugs in the twelve months before their arrest. 
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Table 3:  Sexual and reproductive characteristics of female inmates at two U.S. federal prisons by  
Trichomonas vaginalis status, 2001 









Ever had vaginal sexual intercourse with a man (%): 
No 1.4 (1.4)3 0.0  (0.0)3 1.5  (1.5)3  
Yes 64.3 (97.4)3 58.3  (97.9)3 64.9 (97.4)3 0.39  (0.53)3 
Missing or inconsistent 
information 34.3 (1.2)
3
 41.7  (2.1)3 33.6 (1.1)3  
Number of lifetime male sexual partners (%): 
None 1.4 (34.7)3 0.0 (39.6)3 1.5 (34.2)3  
1-4 28.6 (28.6)3 29.2 (29.2)3 28.5 (28.5)3 0.51  (0.69)3 
≥5 33.9 (33.9)3 27.1 (27.1)3 34.6 (34.6)3  
Missing or inconsistent 
information 36.1 (2.8)
3
 43.8 (4.2)3 35.3 (2.6)3  
Number of male sexual partners in the 3 months before arrest (%): 
None 9.7 (15.4)3 8.3 (18.8)3 9.8 (15.0)3  
1 32.2 (54.6)3 33.3 (52.1)3 32.0 (54.9)3 0.82  (0.55)3 
≥2 21.1 (29.0)3 16.7 (27.1)3 21.6 (29.2)3  
Missing or inconsistent 
information 37.1 (1.0)
3
 41.7 (2.1)3 36.6 (0.9)3  
Ever had a non-regular (short-term or one time) male sexual partner (%): 
No 34.3 (34.3)3 35.4 (35.4)3 34.2 (34.2)3  
Yes 34.5 (61.9)3 35.4 (60.4)3 34.4 (62.1)3 0.95  (0.97)3 
Missing or inconsistent 
information 31.2 (3.8)
3
 29.2 (4.2)3 31.4 (3.7)3  
Ever had vaginal sexual intercourse with a woman (%): 
No 66.9 (68.0)3 72.9 (70.8)3 66.2 (67.8)3  
Yes  8.3 (28.0)3 6.2 (25.0)3 8.5 (28.3)3 0.64  (0.89)3 
Missing or inconsistent 
information 24.8 (3.9)
3
 20.8 (4.2)3 25.3 (3.9)3  
Ever exchanged sexual 
activity for money or drugs 
(%) 
16.8 8.7 17.6 0.12 
Ever pregnant (%) 88.0 93.8 87.4 0.20 
Birth control in the 12 months before prison entry (%): 
None 33.9 31.2 34.2  
Condoms 29.3 35.4 28.6 0.62 
Other form of birth control 36.8 33.3 37.1  
Pelvic examination before prison entry (%): 
Never or ≥12 months 54.2 54.2 54.2  
<12 months 31.0 37.5 30.3 0.33 
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Don’t know/missing 
information 14.8 8.3 15.5 
 
Current symptoms (%):     
Abnormal or unusual 
vaginal discharge 19.1 25.5 18.5 0.24 
Vaginal irritation, itch or 
unusual odor 16.9 14.9 17.1 0.70 
Lower abdominal or pelvic 
pain 18.5 21.3 18.2 0.61 
Vaginal bleeding or spotting 
other than normal period 6.4 12.8 5.7 0.11 
Pain during urination 4.8 4.3 4.8 1.00 
Current chlamydia or 
gonorrhea (%) 1.8 4.2 1.5 0.21 
1 Total number may vary slightly for each characteristic due to missing responses. 
2 P-values were calculated by Chi-squared or Fisher’s exact tests.  
3 Based on original participant responses without taking into consideration consistency of responses across related 
questions. 
 
